Hematology and Oncology Book

http://www.fpnotebook.com/

Ticlopidine

Aka: Ticlopidine, Ticlid
  1. Mechanism
    1. Blocks Platelet ADP
    2. Inhibits platelet aggregation
  2. Indications
    1. Consider other agents (e.g. Plavix) due to toxicity
    2. Cerebrovascular Accident Prevention
  3. Adverse Effects
    1. Thrombotic Thrombocytopenic Purpura (TTP)
    2. Neutropenia
  4. Dosing (Avoid if possible)
    1. Ticlid 250 mg PO bid with food

Ticlopidine (C0040207)

Definition (MSH) Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis.
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D013988
SnomedCT 108971003, 386950000
English Ticlopidine, Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro-, ticlopidine (medication), ticlopidine, Ticlopidine [Chemical/Ingredient], Ticlopidine (product), Ticlopidine (substance), TICLOPIDINE
Swedish Tiklopidin
Czech tiklopidin
Finnish Tiklopidiini
Russian TIKLOPIDIN, ТИКЛОПИДИН
Japanese チクロピジン
Polish Tyklopidyna
Spanish ticlopidina (producto), ticlopidina (sustancia), ticlopidina, Ticlopidina
French Ticlopidine
German Ticlopidin
Italian Ticlopidina
Portuguese Ticlopidina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Ticlid (C0733418)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D013988
English Roche Brand of Ticlopidine Hydrochloride, ticlid, Ticlid
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree